Rimidi and Companion Medical announced a first-of-its-kind partnership to enhance data visualization for clinicians treating high-risk patients with diabetes who are on insulin therapy. The collaboration integrates Companion Medical’s connected device, InPen™, the first and only FDA-cleared, smart insulin pen paired with an integrated diabetes management app, into Rimidi’s platform by pushing insulin dosing data from the InPen through the cloud.Integration BenefitsThis partnership reduces the
Read More
Glooko Integrates Insulin Data with Companion Medical’s Smart Insulin Injection Pen
Glooko and Companion Medical have announced an integrated data partnership agreement that will enable insulin data from users of the InPen Smart Insulin Injection Pen to be integrated into the Glooko Enterprise diabetes data management system and Glooko Mobile App.
Impact of Integration
The announcement of this integration is significant because InPen is the first “smart” insulin pen to introduce its data integration and compatibility with the Glooko platform
Read More
Amazon Choice Integrates with One Drop for Diabetes and Hypertension Management
One Drop, a provider of digital therapeutics solutions, today announced an integration partnership with Amazon’s exclusive health brand, Choice. The integration with One Drop’s app will provide Amazon’s Choice customers living with diabetes and hypertension with affordable, accessible, and comprehensive digital health management services.One Drop/Amazon Choice Integration BenefitsLaunched in late 2018, Amazon Choice was developed by Arcadia Group to offer an array of affordable medical devices
Read More
NHS England Publishes New Guidelines on Flash Glucose Monitors for Type 1 Diabetes Patients
NHS England recently published clinical guidance for flash glucose monitors that outlines funding arrangements for patients with type 1 diabetes and the qualifying criteria to support local health groups. According to NHS England, an estimated 260,000 in England suffer from type 1 diabetes.Starting in April, the NHS will provide the technology for one in five of those with type 1 diabetes in England. Those who qualify include:- People with type 1 diabetes who need intensive monitoring (more than
Read More
New Saliva Glucose Biosensor Could Eliminate Finger Pricks for Diabetes
New non-invasive, saliva-based glucose test measures glucose in saliva rather than blood could eliminate finger pricks for diabetes management.The iQ Group Global, a Sydney, Australia-based consortium of life science and financial services companies has unveiled the Saliva Glucose Biosensor, a non-invasive, saliva-based glucose test for diabetes management that measures glucose in saliva rather than blood. The saliva-based glucose test could eliminate painful finger pricks for diabetes
Read More
CDC Recognizes Lark Health’s A.I. Diabetes Prevention Program
Lark Health, a chronic disease prevention platform, today announced that its AI-based Diabetes Prevention Program (DPP) has received Full Recognition status from the Centers for Disease Control and Prevention. CDC Full Recognition is the highest level of clinical recognition for the DPP, and Lark is now the only DPP that uses cutting edge A.I. to be awarded this recognition.Lark's DPP is the second-largest in the country and one of the fastest-growing. Lark's A.I. platform is augmented by
Read More
Abbott Integrates Insulin Dose Data with Novo Nordisk Insulin Pens
Abbott and Novo Nordisk today announced a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk pre-filled and durable connected pens directly into the digital health tools compatible with the FreeStyle Libre system (FreeStyle LibreLinkii mobile app and LibreViewiii cloud-based system). The integration between Abbott and Novo Nordisk’s products will enable healthcare professionals, caregivers and people with diabetes to view glucose and insulin data together to help
Read More
UCSF Launches SUGAR Clinical Trial Study to Compare Livongo’s Diabetes Management Program to Standard Diabetes Care
Applied Health Signals company Livongo Health, today announced the launch of the Study to Understand Gaining Access to Blood Glucose Records (SUGAR), or SUGAR study, a randomized controlled trial in collaboration with the University of California, San Francisco (UCSF). The aim of the clinical trial is to measure the impact of the Livongo for Diabetes program compared to the average standard of care approach to diabetes management utilizing a traditional Bluetooth glucose meter. SUGAR Study
Read More
Health2047 Spin Out Launches with $2M to Build Platform for People Living with Prediabetes
Health2047 Inc., an American Medical Association-backed company that develops and commercializes solutions to transform healthcare at the system level, today announced the spin out of First Mile Care. With $2M in seed funding, First Mile Care is a preventive chronic care startup that is building an affordable, scalable and sustainable platform to improve the lives of people who have prediabetes. Development is already underway for First Mile Care’s initial platform offering is based on the
Read More
10 Major Trends Shaping The Global Digital Diabetes Market
In the last two years, the digital diabetes care market has seen a substantial progress. In the new report, Digital Diabetes Care Market 2018-2022: Ready to Take Off, Research2Guidance demonstrates how the improvement of digital diabetes solutions has resulted in the increasing demand for them among patients and healthcare organizations. According to the report, the digital diabetes care market has reached a tipping point, which will result in the sustainable growth in the
Read More